Clinical Trial Update: A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study evaluating a Bevacizumab-based combination with Paclitaxel and Carboplatin in non-small cell lung cancer; recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Mabscale, LLC | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: RECRUITING